RU98124036A -
METHOD FOR REHABILITATION OF PATIENTS WITH GASTRODUODENAL PATHOLOGY WITH HYPER SECRET SYNDROME
- Google Patents
METHOD FOR REHABILITATION OF PATIENTS WITH GASTRODUODENAL PATHOLOGY WITH HYPER SECRET SYNDROME
Info
Publication number
RU98124036A
RU98124036ARU98124036/14ARU98124036ARU98124036ARU 98124036 ARU98124036 ARU 98124036ARU 98124036/14 ARU98124036/14 ARU 98124036/14ARU 98124036 ARU98124036 ARU 98124036ARU 98124036 ARU98124036 ARU 98124036A
Институт медицинской климатологии и восстановительного лечения СО РАМН
Filing date
Publication date
Application filed by Институт медицинской климатологии и восстановительного лечения СО РАМНfiledCriticalИнститут медицинской климатологии и восстановительного лечения СО РАМН
Priority to RU98124036ApriorityCriticalpatent/RU2158596C2/en
Priority claimed from RU98124036Aexternal-prioritypatent/RU2158596C2/en
Publication of RU98124036ApublicationCriticalpatent/RU98124036A/en
Application grantedgrantedCritical
Publication of RU2158596C2publicationCriticalpatent/RU2158596C2/en
Способ реабилитации больных гастродуоденальной патологией с гиперсекреторным синдромом, включающий диетотерапию, физиопроцедуры, прием внутрь питьевой минеральной воды, отличающийся тем, что в качестве питьевой минеральной воды используют азотно-кремнистую гидрокарбонатно-сульфатную натриевую воду температуры 40-42°С в дозе 2-2,5 мл на кг массы тела на прием, через 1,5 часа после еды, 3 раза в день, при наличии ночных болей - 4 раза (последний прием - на ночь), в течение 22 дней, с кратностью курса 1-2 раза в год с учетом сезонности и частоты обострения заболевания.A method of rehabilitation of patients with gastroduodenal pathology with hypersecretory syndrome, including diet therapy, physiotherapy, ingestion of drinking mineral water, characterized in that nitrogen-siliceous hydrocarbonate-sulfate sodium water at a temperature of 40-42 ° C in a dose of 2-2 is used as drinking mineral water 5 ml per kg of body weight per reception, 1.5 hours after a meal, 3 times a day, in the presence of night pain - 4 times (last dose - at night), for 22 days, with a multiplicity of 1–2 times year seasonally and frequency aggravated disease
Novel tricyclic compounds, spla inhibiting method, method of soothing pathological consequences of diseases associated with spla, method of treating such diseases, novel intermediate compounds, method of obtaining tricyclic compounds and application of tricyclic compounds in production of a drug
Use of inhibitors of the sodium hydrogen exchanger for the preparation of a drug for the prevention of organ dysfunction and diseases related to a particular age and for a prolonged life
New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease